JENNIFER MARTIN: Open Payments
NPI 1477704559 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,913 in 101 payments from 12 companies in 2025. Trend: 2023 $984 · 2024 $455 · 2025 $1,913
Food & beverage: $1,881Travel & lodging: $31
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $899 |
| Janssen Biotech, Inc. | 28 | $345 |
| Novartis Pharmaceuticals Corporation | 6 | $162 |
| Lilly USA, LLC | 4 | $110 |
| REVANCE THERAPEUTICS, INC. | 2 | $97 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Galderma Laboratories, L.P. | 2 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| GENZYME CORPORATION | 2 | $41 |
| LEO Pharma Inc. | 1 | $28 |
Products named: TREMFYA, BOTOX, RINVOQ, SKYRIZI, COSENTYX, DAXXIFY, TALTZ, Sotyktu.
Industry payments across WA — which companies pay providers there.
